Jonathan Lim: A Unique Opportunity for Clinical Research in Late Phase Tumour Trials
Jonathan Lim/LinkedIn

Jonathan Lim: A Unique Opportunity for Clinical Research in Late Phase Tumour Trials

Jonathan Lim, Co-Lead of The Manchester Immuno-Oncology Network (MION) and Lead of The Christie International Fellowship Program for Medical Oncology at The Christie NHS Foundation Trust, shared a post on LinkedIn:

New opportunity!

An exciting opportunity has arisen within the Research and Innovation Division at The Christie NHS Foundation Trust. We are looking to appoint a Senior Clinical Research Fellow to provide medical support to the for the ‘Late phase Pan Tumor Research Team‘ led by Dr. Jamie Weaver.

A diverse range of clinical research trials are in progress and, following training, the post holder will be expected to participate in these studies as a sub-investigator. These include late phase trials of small molecule inhibitors, next-generation chemotherapy trials, combination/multi-modality phase I trials, molecular characterization/translational studies.

The deadline of applications is 31 March of 2026″

Apply Here

Other articles featuring Jonathan Lim on OncoDaily.